India in January 2022 witnessed the much-awaited market authorization of two indigenous Covid-19 vaccines Covishield and Covaxin by the Drugs Controller of India (DCGI) subject to certain conditions mentioned by the authorities. This means the vaccines will be used as a permitted drug for the adult population concerning certain conditions w.e.f. 19^th January 2022. Till now, these vaccines were only available for restricted use in case of emergencies.